Alzheimer's Disease Trial, Not Yet Recruiting NCT07533084 Sponsor: Neuromed IRCCS Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Not Yet Recruiting

NCT07533084
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged 65 or older who live in Italy
  • People with no memory or thinking problems (considered cognitively healthy)
  • People who feel they have memory problems but have no formal diagnosis (subjective memory complaints)
  • People who have been diagnosed with mild cognitive impairment (MCI) — a condition where there are noticeable memory or thinking changes, but daily life is mostly unaffected
  • People who have been diagnosed with probable Alzheimer's disease
  • People diagnosed with Alzheimer's disease or another form of dementia (for later stages of the trial)
  • People who have been formally diagnosed with a mental health condition (for later stages of the trial)
  • Cognitively healthy people who score at or above a certain level on standard memory and thinking tests, and who have no diagnosis of depression, MCI, or dementia
  • People with subjective memory complaints who score at or above a certain level on standard memory tests, report noticing memory problems themselves or have had this noted by a family member or clinician, and have no diagnosis of depression, MCI, or dementia
  • People with MCI who have a memory test score in a specific range, have reported memory decline (or had it noted by a family member or clinician), have no depression or dementia diagnosis, and can still manage daily activities independently
  • People with probable Alzheimer's disease who show a decline from their previous level of functioning, have memory or other thinking difficulties, and score below a certain threshold on standard cognitive tests

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People under the age of 65
  • People who do not live in Italy
  • People who have been diagnosed with depression or another psychiatric disorder (for Stage 1)
  • People who have a form of dementia other than Alzheimer's disease (for Stage 1)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 17 August 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Luana Dr Gilio, Neuromed IRCCS

Phone: +393404757480

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Neuromed IRCCS
Registry
ClinicalTrials.gov
Start date
1 September 2026
Est. completion
27 November 2027

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Italian Validation and Factor Structure of the dynamic Neurocognitive Adaptation Scale (dNA)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 17 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov